The Experts below are selected from a list of 255 Experts worldwide ranked by ideXlab platform
R R Perrella - One of the best experts on this subject based on the ideXlab platform.
-
uterine fibroid embolization nonsurgical treatment for symptomatic fibroids
Journal of The American College of Surgeons, 2001Co-Authors: Bruce Mclucas, Louis Adler, R R PerrellaAbstract:Abstract Background: Earlier studies demonstrated the efficacy of uterine fibroid embolization (UFE). We seek to demonstrate the success of the procedure in a community hospital setting, and we attempt to identify patients likely not to benefit from embolization, if possible, before the procedure. Study Design: The study followed all women treated with UFE for menorrhagia or postmenopausal bleeding at a community hospital between 1997 and 1999. Relief of symptoms, ultrasound changes, and complications were documented. Six months after the procedure, analysis was performed on ultrasound and interview data from patients who underwent UFE. A smaller number of patients has been followed for 12 months and were available for the analysis. We examined characteristics of patients and procedures performed in an attempt to identify likely failures of treatment. We calculated complication and failure rates based on the entire group of patients. Results: From 183 patients who applied for UFE, 16 were excluded because of pathologic conditions found during preembolization evaluation; 167 women had an embolization, 163 were successfully embolized bilaterally, and 4 were embolized unilaterally because of technical failure. Eighty-eight percent of the patients (147 of 167 patients) reported an improvement or stabilization of symptoms 6 months after UFE. Forty-six patients followed for 12 months experienced Myoma shrinkage of 37% (a significant shrinkage over 6 months, p Conclusions: Uterine fibroid embolization, an alternative treatment for Myomas, offering low morbidity, can be performed in a community hospital setting. Eighty-eight percent of patients reported improvement or stabilization of symptoms. Total uterine volume decreased an average of 49% at 6 months after embolization. Shrinkage was unaffected by the size of the Uterus, Myoma, or patient characteristic before UFE. Longterm followup study reveals a significant continuing shrinkage of total uterine volume and Myomata at 12 months. There has been no regrowth of fibroids. Earlier surgery was a factor predicting failure of UFE in our series. The risks to future fertility were small.
Zou Kunxiang - One of the best experts on this subject based on the ideXlab platform.
-
the clinical analysis of b sonography diagnosis of Uterus Myoma
Journal of Gannan Medical University, 2011Co-Authors: Zou KunxiangAbstract:Objective:To discuss the clinical value of B-sonography diagnosis of Uterus Myoma.Method:Analyzing 96 cases with Uterus Myoma by B-sonography,with the combination of surgery and pathological diagnosis.Result:In the 96 cases diagnosed by B-sonography with Uterus Myoma,92 cases were proved with the disease after the surgery and the pathology verifier.The the accuracy rate of diagnosis was 95.8%.Conclusion: B-sonography diagnosis of Uterus Myoma is to be performed,no wound,no pain,the detection accuracy rate is high.It is easy to make a follow-up visit and reexamination.The timely treatment can be done for the patients with strict operative indications.However,B-ultrasound diagnosis for Uterus Myoma also has certain error diagnostic rate and careful efforts should be made to reduce the mis-diagnosis.
Bruce Mclucas - One of the best experts on this subject based on the ideXlab platform.
-
uterine fibroid embolization nonsurgical treatment for symptomatic fibroids
Journal of The American College of Surgeons, 2001Co-Authors: Bruce Mclucas, Louis Adler, R R PerrellaAbstract:Abstract Background: Earlier studies demonstrated the efficacy of uterine fibroid embolization (UFE). We seek to demonstrate the success of the procedure in a community hospital setting, and we attempt to identify patients likely not to benefit from embolization, if possible, before the procedure. Study Design: The study followed all women treated with UFE for menorrhagia or postmenopausal bleeding at a community hospital between 1997 and 1999. Relief of symptoms, ultrasound changes, and complications were documented. Six months after the procedure, analysis was performed on ultrasound and interview data from patients who underwent UFE. A smaller number of patients has been followed for 12 months and were available for the analysis. We examined characteristics of patients and procedures performed in an attempt to identify likely failures of treatment. We calculated complication and failure rates based on the entire group of patients. Results: From 183 patients who applied for UFE, 16 were excluded because of pathologic conditions found during preembolization evaluation; 167 women had an embolization, 163 were successfully embolized bilaterally, and 4 were embolized unilaterally because of technical failure. Eighty-eight percent of the patients (147 of 167 patients) reported an improvement or stabilization of symptoms 6 months after UFE. Forty-six patients followed for 12 months experienced Myoma shrinkage of 37% (a significant shrinkage over 6 months, p Conclusions: Uterine fibroid embolization, an alternative treatment for Myomas, offering low morbidity, can be performed in a community hospital setting. Eighty-eight percent of patients reported improvement or stabilization of symptoms. Total uterine volume decreased an average of 49% at 6 months after embolization. Shrinkage was unaffected by the size of the Uterus, Myoma, or patient characteristic before UFE. Longterm followup study reveals a significant continuing shrinkage of total uterine volume and Myomata at 12 months. There has been no regrowth of fibroids. Earlier surgery was a factor predicting failure of UFE in our series. The risks to future fertility were small.
Jiang Yong-neng - One of the best experts on this subject based on the ideXlab platform.
-
Experience of Applying Transcatheter Uterine Arterial Embolization to Treat Uterus Myoma
Journal of Kunming Medical University, 2020Co-Authors: Jiang Yong-nengAbstract:Objective To investigate the clinical value of transcatheter super-selective uterine arterial embolization to treat Uterus Myoma. Methods Twenty-three patients with Uterus Myoma were performed angiography and uterine arterial embolization using poly vinyl alcohol(PVA)particle and gelfoam.The imaging appearance of angiography,the curative effects and the changing of tumor volume were summarized and analyzed according to 12 cases among the total who were performed completely post-operative follow-up. Results Angiography showed that the diameter of uterine artery increased,the vessels displaced for squeezed and the tumor were stained by contrast medium before embolization.The quantity of menstruation decreased,and the tumor volume reduced after therapy.Conclusion Transcatheter uterine arterial embolization to treat Uterus Myoma is a simple effective method to ameliorate clinical symptom of patient with Uterus Myoma.
Liu Chuqin - One of the best experts on this subject based on the ideXlab platform.
-
Clinical observation of transcatheter uterine artery embolization for uterine Myoma treatment
Chinese Journal of Primary Medicine and Pharmacy, 2020Co-Authors: Liu ChuqinAbstract:Objective To investigate the efficacy of transcatheter uterine artery embolization for uterine Myoma treatment.Methods 46 cases of uterine Myomas were treated by TUAE using lipiodol-pingyanmycin emulsion mixed gelfoam particles and observe for efficacy.Results It was shown that uterine Myoma was mainly supplied by dual uterine arteries.The volume of Uterus Myoma decreased 42.6%,65.3%,76.7% and 83.4% respectively.3,6,12 and 18 months after TUAE.All clinical symptoms of the 46 patients were relieved.Conclusion TUAE has a good effect on uterine Myomas and is a minimally invasive and safe therapy with little complications.
